305 related articles for article (PubMed ID: 15447983)
1. Hypermethylation in histologically distinct classes of breast cancer.
Bae YK; Brown A; Garrett E; Bornman D; Fackler MJ; Sukumar S; Herman JG; Gabrielson E
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
4. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
Hu XC; Wong IH; Chow LW
Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701
[TBL] [Abstract][Full Text] [Related]
6. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
9. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
10. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
Parrella P; Poeta ML; Gallo AP; Prencipe M; Scintu M; Apicella A; Rossiello R; Liguoro G; Seripa D; Gravina C; Rabitti C; Rinaldi M; Nicol T; Tommasi S; Paradiso A; Schittulli F; Altomare V; Fazio VM
Clin Cancer Res; 2004 Aug; 10(16):5349-54. PubMed ID: 15328171
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
13. CpG methylation of the ERalpha and ERbeta genes in breast cancer.
Kim SJ; Kim TW; Lee SY; Park SJ; Kim HS; Chung KW; Lee ES; Kang HS
Int J Mol Med; 2004 Aug; 14(2):289-93. PubMed ID: 15254780
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
15. Hierarchical clustering of lung cancer cell lines using DNA methylation markers.
Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
17. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.
Radpour R; Kohler C; Haghighi MM; Fan AX; Holzgreve W; Zhong XY
Oncogene; 2009 Aug; 28(33):2969-78. PubMed ID: 19503099
[TBL] [Abstract][Full Text] [Related]
18. DNA hypermethylation in breast cancer and its association with clinicopathological features.
Li S; Rong M; Iacopetta B
Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926
[TBL] [Abstract][Full Text] [Related]
19. Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
Jerónimo C; Costa I; Martins MC; Monteiro P; Lisboa S; Palmeira C; Henrique R; Teixeira MR; Lopes C
Clin Cancer Res; 2003 Aug; 9(9):3413-7. PubMed ID: 12960130
[TBL] [Abstract][Full Text] [Related]
20. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]